Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Bone

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S8756-3282(00)00457-9PMID 11336918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide and bone

  2001cited by this paper
• Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction

  2000cited by this paper
• Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation.

  2000cited by this paper
• Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.

  2000cited by this paper
• N-acetyl-L-cysteine enhances interleukin-1beta-induced nitric oxide synthase expression.

  1999cited by this paper
• Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK).

  1999cited by this paper
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

  1999cited by this paper
• Interleukin-17 stimulates the expression of IkappaB alpha mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines.

  1999cited by this paper
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

  1999cited by this paper
• Interleukin‐17: A New Bone Acting Cytokine In Vitro

  1999cited by this paper
• Required and nonessential functions of nuclear factor-kappa B in bone cells.

  1999cited by this paper
• Genomic organization and chromosomal mapping of mouse nuclear factor kappa B 2 (NFKB2)

  1999cited by this paper
• RANK is essential for osteoclast and lymph node development.

  1999cited by this paper
• Mitogen‐activated protein kinase and nuclear factor κB together regulate interleukin‐17–induced nitric oxide production in human osteoarthritic chondrocytes: Possible role of transactivating factor mitogen–activated protein kinase–activated protein kinase (MAPKAPK)

  1999cited by this paper
• The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen‐Containing Bisphosphonates

  1999cited by this paper
• Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κB*

  1998cited by this paper
• IL‐1α, IL‐1β, IL‐6, and TNF‐α Steady‐State mRNA Levels Analyzed by Reverse Transcription‐Competitive PCR in Bone Marrow of Gonadectomized Mice

  1998cited by this paper
• Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone.

  1998cited by this paper
• A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.

  1998cited by this paper
• Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

  1998cited by this paper
• IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice.

  1998cited by this paper
• Osteopetrosis in mice lacking NF-κB1 and NF-κB2

  1997cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• NF‐κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells

  1997cited by this paper
• The Michael Mason Prize Essay 1997. Nitric oxide and bone: what a gas!

  1997cited by this paper
• Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

  1997cited by this paper
• Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage.

  1997cited by this paper
• Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins.

  1996cited by this paper
• Cloning of the murine relA (p65 NF-kappa B) gene and comparison to the human gene reveals a distinct first intron.

  1996cited by this paper
• Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4.

  1996cited by this paper
• The role of reactive oxygen intermediates in osteoclastic bone resorption.

  1995cited by this paper
• Expression and functional role of nitric oxide synthase in osteoblast‐like cells

  1995cited by this paper
• Nitric oxide: A cytokine‐induced regulator of bone resorption

  1995cited by this paper
• In vitro and Ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis

  1995cited by this paper
• Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity.

  1995cited by this paper
• Mechanisms controlling nitric oxide synthesis in osteoblasts.

  1995cited by this paper
• Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase.

  1994cited by this paper
• Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.

  1994cited by this paper
• Cytokines induce nitric oxide production in mouse osteoblasts.

  1994cited by this paper
• Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA.

  1993cited by this paper
• Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture

  1993cited by this paper
• Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.

  1992cited by this paper
• RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B

  1992cited by this paper
• Sodium nitroprusside increases cyclic GMP in fetal rat bone cells and inhibits resorption of fetal rat limb bones.

  1992cited by this paper
• Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

  1991cited by this paper
• Macrophage NO2- production as a sensitive and rapid assay for the quantitation of murine IFN-gamma.

  1991cited by this paper
• Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal

  1990cited by this paper
• Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.

  1990cited by this paper
• The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli.

  1990cited by this paper
• Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria

  1983cited by this paper
• Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

  1982cited by this paper
• Structure of wild-type and mutant mouse beta 2-microglobulin genes.

  1982cited by this paper
• Structure of wild-type and mutant mouse β2-microglobulin genes

  1982cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation

  year unknowncited by this paper

• Nitric oxide synthases: A delicate dance between bone regeneration and neuronal birth.

  2025cites this paper
• Osteoimmunology: Crosstalk Between T Cells and Osteoclasts in Osteoporosis

  2025cites this paper
• From bench to bedside - is there a role of IL-17 drugs in rheumatoid arthritis?

  2024cites this paper
• New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis

  2023cites this paper
• The Role of Tocotrienol in Arthritis Management—A Scoping Review of Literature

  2023cites this paper
• Interplay between fat cells and immune cells in bone: Impact on malignant progression and therapeutic response.

  2022cites this paper
• 8-Nitro-cGMP suppresses mineralization by mouse osteoblasts

  2022cites this paper
• Interleukin-17A Interweaves the Skeletal and Immune Systems

  2021cites this paper
• Th17 Cells in Viral Infections—Friend or Foe?

  2021cites this paper
• Contribution of Macrophages and T Cells in Skeletal Metastasis

  2020cites this paper
• Molecular and Cellular Mechanisms of Arthritis in Children and Adults: New Perspectives on Applied Photobiomodulation

  2020cites this paper
• Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis

  2020cites this paper
• Untersuchungen zur Assoziation von Del-1, PTX3, LFA-1 und IL-17α mit der chronischen Parodontitis

  2019cites this paper
• Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis

  2019cites this paper
• IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels

  2019cites this paper
• Serum levels of resistin and interleukin-17 are associated with increased cartilage defects and bone marrow lesions in patients with knee osteoarthritis

  2017cites this paper
• Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases.

  2016cites this paper
• Cytokines and Nitric Oxide in Immunopathogenesis of IBD and Potential Therapeutic Approaches

  2016cites this paper
• Interaction of a small molecule Natura-α and STAT3-SH2 domain to block Y705 phosphorylation and inhibit lupus nephritis.

  2016cites this paper
• Role of periodontal ligament fibroblasts in osteoclastogenesis: a review.

  2015cites this paper
• T helper Regulation and Anti-Cytokine Therapy in Asthma

  2015cites this paper
• Biochemical effects of Cleome droserifolia on alloxan -induced diabetes in rats: Role of insulin, oxidative stress and inflammation

  2015cites this paper
• Biochemical effects of Hydroclathrus clathratus on alloxan -induced diabe- tes in rats: Role of insulin, oxidative stress and inflammation

  2015cites this paper
• Immunoexpression of interleukin 17 in apical periodontitis lesions.

  2014cites this paper
• Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis

  2014cites this paper
• Whole exome sequencing of a single osteosarcoma case—integrative analysis with whole transcriptome RNA-seq data

  2014cites this paper
• Quercetin inhibits inflammatory bone resorption in a mouse periodontitis model.

  2013cites this paper
• The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases

  2013cites this paper
• IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid

  2013cites this paper
• The role of cytokines in inflammatory bone loss

  2013cites this paper
• IL-17 and IL-11 GCF Levels in Aggressive and Chronic Periodontitis Patients: Relation to PCR Bacterial Detection

  2012cites this paper
• The role of prophylactic ibuprofen and N-acetylcysteine on the level of cytokines in periapical exudates and the post-treatment pain

  2012cites this paper
• FACULDADE DE ODONTOLOGIA DE ARARAQUARA

  2012cites this paper
• Role of TH-17 cells in rheumatic and other autoimmune diseases.

  2011cites this paper
• Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes

  2011cites this paper
• Therapeutic targeting of osteoclast function and pathways

  2011cites this paper
• Cytokine responses against periodontal infection: protective and destructive roles.

  2010cites this paper
• Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches

  2010cites this paper
• Interleukin‐17 and systemic lupus erythematosus: current concepts

  2009cites this paper
• IL‐17 is involved in bone resorption in mouse periapical lesions

  2009cites this paper
• p38 MAPK signaling mediates IL-17-induced nitric oxide synthase expression in bone marrow cells

  2009cites this paper
• Breaking old paradigms: Th17 cells in autoimmune arthritis.

  2009cites this paper
• Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity.

  2008cites this paper
• Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma.

  2007cites this paper
• Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.

  2007cites this paper
• Cells Regulate Tumor Burden and Osteolysis in Bone Dependent Mechanisms in Breast Cancer − B κ Nuclear Factor-Updated

  2005cites this paper
• Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.

  2005cites this paper
• Bone Morphogenetic Proteins, Antagonists and Receptors in Prostate Cancer

  2005cites this paper
• Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells

  2005cites this paper
• Cytokines link osteoblasts and inflammation: microarray analysis of interleukin‐17‐ and TNF‐α‐induced genes in bone cells

  2005cites this paper
• Inducible nitric oxide synthase activation by interleukin-17.

  2004cites this paper
• Interleukine-17-induced inhibitory effect on late stage murine erythroid bone marrow progenitors.

  2004cites this paper
• Biology of recently discovered cytokines: Interleukin-17 – a unique inflammatory cytokine with roles in bone biology and arthritis

  2004cites this paper
• Review Biology of recently discovered cytokines: Interleukin-17 - a unique inflammatory cytokine with roles in bone biology and

  2004cites this paper
• IL-17 as a contributor to inflammation and destruction in rheumatoid arthritis

  2004cites this paper
• Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cells.

  2004cites this paper
• Interleukin‐17: the missing link between T‐cell accumulation and effector cell actions in rheumatoid arthritis?

  2004cites this paper
• Effects of nitric oxide in orthodontic tooth movement in rats.

  2004cites this paper
• Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members*

  2004cites this paper
• CHAPTER 20 – Interleukin-17 [IL-17, IL-25]

  2003cites this paper
• T-cell-derived Interleukin-17 Regulates the Level and Stability of Cyclooxygenase-2 (COX-2) mRNA through Restricted Activation of the p38 Mitogen-activated Protein Kinase Cascade

  2003cites this paper
• NFκB: A Pivotal Transcription Factor in Prostate Cancer Metastasis to Bone

  2003cites this paper
• Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.

  2003cites this paper
• Survey Interleukin-17 family and IL-17 receptors

  2003cites this paper
• Interleukin-17 family and IL-17 receptors.

  2003cites this paper
• The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells

  2003cites this paper
• IL-17 cytokine/receptor families: emerging targets for the modulation of inflammatory responses

  2003cites this paper
• IL‐17: prototype member of an emerging cytokine family

  2002cites this paper
• Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis.

  2002cites this paper
• Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro.

  2002cites this paper
• Interleukin 17 synergises with tumour necrosis factor α to induce cartilage destruction in vitro

  2002cites this paper
• Catabolic and anabolic signals in bone: therapeutic implications

  2001cites this paper